Search our portfolio

GlycoVaxyn

Close
GlycoVaxyn

GlycoVaxyn offers a solution to produce therapeutic glycoproteins faster and at lower costs. The company will use its technology platform to develop novel conjugated vaccines which cannot be produced by traditional methods.

Details

Contact:
Francesco De Rubertis, Roman Fleck
Website:
www.glycovaxyn.com
Status:
Current
Sector(s):
Protein drugs, Vaccines
Geography:
Switzerland

News

May 21 2008
GlycoVaxyn Appoints Philippe Dro as CEO
Jul 16 2007
GlycoVaxyn AG Completes CHF 11.5 Million Series A Financing

Jobs

MIS Data Analyst